Furthermore, through the integration of medical imaging examination data obtained from patients with BPH, we have elucidated the correlation between c-Fos expression and both the severity and progression of clinical symptoms in BPH, utilizing indicators such as prostate volume and IPP. This evidence concerns the gene FOS and benign prostatic hyperplasia.